NCT03136679View on ClinicalTrials.gov

Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease

UnknownOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

April 30, 2022

Study Completion Date

December 31, 2022

Conditions
Mild Cognitive ImpairmentAlzheimer Disease
Trial Locations (1)

75231

RECRUITING

Baylor AT&T Memory Center, Dallas

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER